1. Home
  2. HIVE vs EOLS Comparison

HIVE vs EOLS Comparison

Compare HIVE & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HIVE Digital Technologies Ltd.

HIVE

HIVE Digital Technologies Ltd.

N/A

Current Price

$1.86

Market Cap

554.0M

Sector

N/A

ML Signal

N/A

Logo Evolus Inc.

EOLS

Evolus Inc.

N/A

Current Price

$7.25

Market Cap

500.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HIVE
EOLS
Founded
1987
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
554.0M
500.0M
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
HIVE
EOLS
Price
$1.86
$7.25
Analyst Decision
Strong Buy
Buy
Analyst Count
9
6
Target Price
$6.89
★ $15.00
AVG Volume (30 Days)
★ 9.2M
689.7K
Earning Date
11-13-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 1.23
EPS
N/A
★ N/A
Revenue
★ $297,791,000.00
$297,176,000.00
Revenue This Year
$24.05
$12.44
Revenue Next Year
$40.34
$17.37
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 158.32
11.61
52 Week Low
$1.73
$3.86
52 Week High
$5.59
$9.31

Technical Indicators

Market Signals
Indicator
HIVE
EOLS
Relative Strength Index (RSI) 29.70 44.78
Support Level $1.73 $7.07
Resistance Level $2.33 $7.28
Average True Range (ATR) 0.13 0.35
MACD 0.00 0.02
Stochastic Oscillator 1.82 39.78

Price Performance

Historical Comparison
HIVE
EOLS

About HIVE HIVE Digital Technologies Ltd.

HIVE Digital Technologies Ltd is a sustainable-energy-focused digital infrastructure company that provides infrastructure solutions through the operation of Tier-1 and Tier-3 data centers. Its computing power is used for high-performance computing (HPC) and for generating hashrate sold to mining pools for cryptocurrency mining. The Company uses cash flow from its hashrate services business to support the expansion of its AI and HPC operations through its subsidiary. The Company focuses on Canada, Sweden, and Paraguay, where low-cost renewable power supports its operations and expansion. It operates in one segment with two revenue streams: the mining and sale of digital currencies and high-performance computing hosting. The majority of its revenue is generated from Bermuda.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: